Drug intelligence / Profile preview

sucrosomial magnesium

Development stage
Preclinical
Lead developer
Pharmanutra
Modality
Small Molecules
Administration
Oral
01

Overview

Sucrosomial magnesium is an oral **dietary supplement** formulation of magnesium in which magnesium oxide is delivered using PharmaNutra's sucrosomial technology, a phospholipid and sucrose ester-based matrix intended to protect the mineral through the gastrointestinal tract and enhance intestinal absorption. The active moiety is elemental magnesium supplied from magnesium oxide, and the product is positioned as a nutraceutical for magnesium repletion and general wellness applications such as support for muscle function, sleep, mood, cardiovascular health, bone health, and exercise performance rather than as a regulated pharmaceutical. Its mechanism is not based on a single drug-like receptor interaction; instead, it provides bioavailable magnesium, an essential mineral cofactor required for numerous enzymatic processes, neuromuscular function, and electrolyte homeostasis. Clinical literature around the formulation primarily emphasizes improved oral bioavailability and gastrointestinal tolerability versus conventional magnesium salts.

Brand names
Ultramag
Other names
magnesium sucrosomialsucrosome magnesiumsucrosomial magnesium oxide

Beyond the preview

Go deeper on sucrosomial magnesium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sucrosomial magnesium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call